furosemide has been researched along with ascorbic acid in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (26.92) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 9 (34.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chepuk, EB; Zlydnikov, DM | 1 |
| Dybing, E | 1 |
| McDonald, SE; Tomson, FN; Wolf, ED | 1 |
| Dixon, SJ; Jaworski, EM; Kulaga, A; Wilson, JX | 1 |
| Cozette, AP; Delpech, N; Donnadieu, P; Huchard, G; Ortiz, JP; Rapior, S | 1 |
| Dixon, SJ; Wilson, JX | 1 |
| Addo, E | 1 |
| Derzsiová, K; Koleják, J; Mydlík, M; Szeghy, D; Takác, M | 1 |
| Fujimura, H; Ito, M; Suzuki, Y; Yamagami, I | 1 |
| Chiou, WL; Lee, MG | 1 |
| Derzsiová, K; Dlhopolcek, P; Mydlík, M; Svác, J; Zemberová, E | 1 |
| Derzsiová, K; Mydlík, M; Rajnic, A; Zemberová, E | 1 |
| Doba, N; Tomiyama, H; Watanabe, G; Yamashina, A; Yoshida, H | 1 |
| McCaig, CD; Reid, B; Song, B; Zhao, M | 1 |
| Airoldi, F; Briguori, C; Colombo, A; Morici, N | 1 |
| Bernstein, SJ; Carlos, RC; Cronin, P; Dwamena, B; Kelly, AM | 1 |
| Hara, I; Kohjimoto, Y; Sasaki, Y | 1 |
| De Capadocia Rosell, J; Jiménez Vizuete, JM; Lozano Serrano, B; Mateo Cerdá, CM | 1 |
| AbdElgawad, H; Asard, H; Boeckx, P; Samson, R; Staelens, J; Verheyen, K; Wuytack, T | 1 |
4 review(s) available for furosemide and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New pharmacological protocols to prevent or reduce contrast media nephropathy.
Topics: Acetylcysteine; Antioxidants; Ascorbic Acid; Contrast Media; Diuretics; Fluid Therapy; Furosemide; Humans; Incidence; Kidney; Mannitol; Renal Insufficiency; Vasoconstriction; Vasodilator Agents | 2005 |
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Ascorbic Acid; Bicarbonates; Clinical Trials as Topic; Contrast Media; Furosemide; Protective Agents; Research Design; Theophylline | 2008 |
[Clinical strategies for prevention of drug-induced urinary calculi].
Topics: Allopurinol; Anti-Bacterial Agents; Ascorbic Acid; Benzbromarone; Calcium; Calcium Compounds; Carbonic Anhydrase Inhibitors; Crystallization; Diuretics; Drug Combinations; Furosemide; Glucocorticoids; Humans; Magnesium Silicates; Oxalates; Protease Inhibitors; Purines; Time Factors; Triamterene; Urinary Calculi; Vitamin D | 2011 |
2 trial(s) available for furosemide and ascorbic acid
| Article | Year |
|---|---|
Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis.
Topics: Adult; Ascorbic Acid; Dietary Proteins; Diuretics; Female; Furosemide; Humans; Kidney Failure, Chronic; Male; Middle Aged; Oxalic Acid; Peritoneal Dialysis, Continuous Ambulatory; Pyridoxine; Urea | 1998 |
Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Cross-Over Studies; Cyclic GMP; Drug Therapy, Combination; Enalapril; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Oxidative Stress | 2003 |
20 other study(ies) available for furosemide and ascorbic acid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
[Clinical course and principles of intensive treatment of hypertoxic forms of influenza complicated by pneumonia].
Topics: Adult; Aminophylline; Ascorbic Acid; Drug Therapy, Combination; Furosemide; gamma-Globulins; Humans; Influenza, Human; Middle Aged; Oxacillin; Phenylephrine; Pneumonia; Strophanthins; Tetracyclines | 1976 |
Methyldopa binding to cells in culture.
Topics: Acetaminophen; Allopurinol; Animals; Ascorbic Acid; Carcinoma, Hepatocellular; Cells, Cultured; Deferoxamine; Dimethylnitrosamine; Edetic Acid; Furosemide; Glutathione; Liver Neoplasms; Maleates; Methyldopa; Neoplasms, Experimental; Protein Binding; Rats; Superoxide Dismutase; Time Factors; Xanthines | 1977 |
Hypopyon in a tortoise.
Topics: Animals; Anterior Chamber; Ascorbic Acid; Chloramphenicol; Eye Diseases; Furosemide; Male; Pneumonia; Suppuration; Turtles | 1976 |
Ascorbate uptake by ROS 17/2.8 osteoblast-like cells: substrate specificity and sensitivity to transport inhibitors.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Ascorbic Acid; Biological Transport; Cells, Cultured; Furosemide; Kinetics; Osteoblasts; Osteosarcoma; Salicylates; Salicylic Acid; Sulfinpyrazone; Tumor Cells, Cultured | 1991 |
[Voluntary poisoning by Cortinarius orellanus: usefulness of an original early treatment after determination of orellanine in the biological fluids and tissues].
Topics: 2,2'-Dipyridyl; Acute Disease; Acute Kidney Injury; Adult; Agaricales; Amino Acids; Ascorbic Acid; Biopsy; Chromatography, Thin Layer; Combined Modality Therapy; Diltiazem; Dopamine; Female; Fluorometry; Furosemide; Hemoperfusion; Humans; Kidney; Mushroom Poisoning; Mycotoxins; Photochemistry; Plasmapheresis; Renal Dialysis | 1991 |
Ascorbic acid transport in mouse and rat astrocytes is reversibly inhibited by furosemide, SITS, and DIDS.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Ascorbic Acid; Astrocytes; Cells, Cultured; Furosemide; Mice; Rats; Rats, Inbred Strains; Stilbenes | 1989 |
Paraquat poisoning.
Topics: Aluminum Compounds; Aluminum Silicates; Antidotes; Ascorbic Acid; Cyclophosphamide; Dexamethasone; Fluid Therapy; Furosemide; Humans; Kaolin; Magnesium Compounds; Paraquat; Silicates | 1987 |
[The effect of furosemide on vitamin C excretion in urine in chronic kidney failure].
Topics: Adult; Ascorbic Acid; Female; Furosemide; Humans; Kidney Failure, Chronic; Male | 1986 |
[Influence of various drugs on tissue permeability].
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Antipyrine; Ascorbic Acid; Bromelains; Coloring Agents; Cysteine; Female; Furosemide; Histamine; Hydrogen-Ion Concentration; Injections, Intradermal; Injections, Subcutaneous; Methods; Papain; Pentobarbital; Pepsin A; Permeability; Pharmacology; Phenylbutazone; Prednisolone; Rats; Rutin; Salicylates; Skin; Skin Absorption; Time Factors | 1969 |
Mechanism of ascorbic acid enhancement of the bioavailability and diuretic effect of furosemide.
Topics: Animals; Ascorbic Acid; Biological Availability; Diuretics; Dogs; Drug Synergism; Drug Therapy, Combination; Furosemide; Intestinal Absorption; Male; Rats; Rats, Sprague-Dawley | 1998 |
[The effect of furosemide on urinary excretion of oxalic acid, vitamin C and vitamin B6 in chronic kidney failure].
Topics: Adult; Ascorbic Acid; Diuretics; Female; Furosemide; Humans; Kidney Failure, Chronic; Male; Middle Aged; Oxalic Acid; Pyridoxine | 1998 |
Wound healing in rat cornea: the role of electric currents.
Topics: Aminophylline; Animals; Ascorbic Acid; Biological Transport; Chlorides; Corneal Injuries; Cyclic AMP; Electric Conductivity; Epithelium, Corneal; Female; Furosemide; Kinetics; Male; Phosphodiesterase Inhibitors; Potassium; Rats; Rats, Sprague-Dawley; Sodium; Wound Healing | 2005 |
[Presentation of a case of Paraquat poisoning].
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Ascorbic Acid; Charcoal; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Diuretics; Fatal Outcome; Furosemide; Gastric Lavage; Hemoperfusion; Humans; Immunosuppressive Agents; Male; Paraquat; Poisoning; Pulmonary Fibrosis; Respiration, Artificial; Respiratory Insufficiency; Rhabdomyolysis; Suicide, Attempted; Vitamin E | 2012 |
The response of the foliar antioxidant system and stable isotopes (δ(13)C and δ(15)N) of white willow to low-level air pollution.
Topics: Air Pollution; Antioxidants; Ascorbic Acid; Carbon Isotopes; Lipid Peroxidation; Nitrogen Dioxide; Nitrogen Isotopes; Plant Leaves; Salix | 2013 |